Dianthus Therapeutics Inc. (DNTH) — Long-term Investment Intensity

Latest as of June 2026: 25.0%

Dianthus Therapeutics Inc. (DNTH) has a Long-term Investment Intensity of 25.0% as of June 2026. Long-term investments of $303.63 Million represent 25.0% of total assets of $1.21 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check DNTH financial resilience to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

25.0%
LT Investments / Total Assets

Long-term Investments

$303.63 Million
USD

Total Assets

$1.21 Billion
USD

Country

USA
NASDAQ

Dianthus Therapeutics Inc. Long-term Investment Intensity (2024–2025)

This chart shows how Dianthus Therapeutics Inc.'s Long-term Investment Intensity has evolved across 2 annual periods from 2024 to 2025. As of June 2026, the intensity stands at 25.0%, reflecting long-term investments of $303.63 Million against total assets of $1.21 Billion USD. For the complete balance sheet picture, see DNTH total assets.

Annual Long-term Investment Intensity for Dianthus Therapeutics Inc. (2024–2025)

The table below presents the year-by-year Long-term Investment Intensity for Dianthus Therapeutics Inc. from 2024 to 2025, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Dianthus Therapeutics Inc. (DNTH) financial obligations for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2025 20.7% $110.14 Million $530.92 Million ▼ -1.1 pp
2024 21.9% $81.73 Million $374.01 Million
pp = percentage points